{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:07:04Z","timestamp":1784740024800,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Renal and urological manifestations are understudied extraintestinal features of inflammatory bowel disease (IBD). Our aim was to estimate their prevalence and identify associated clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, single-center, observational study, included IBD patients with at least 1 year of follow-up and documented renal function monitoring. Demographic, clinical, and laboratory data were collected. The primary outcome was renal injury defined as acute kidney injury (AKI), chronic kidney disease (CKD), or both during follow-up. Secondary outcomes were AKI, CKD, and urolithiasis. Associations were assessed using univariate and multivariable logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 660 patients were included [379 (57.4%) male; 368 (56%) had Crohn\u2019s disease and 292 (44%) ulcerative colitis]. The primary outcome occurred in 54 patients (8.2%), AKI in 23 (3.5%), CKD in 35 (5.3%), and urolithiasis in 48 (7.3%). Independent risk factors for renal injury included IBD-related surgery [adjusted odds ratio (aOR): 2.69, 95% confidence interval (CI): 1.25\u20135.80,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.012], extensive ulcerative colitis (aOR: 2.81, 95% CI: 1.11\u20137.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.035), arterial hypertension (aOR: 2.43, 95% CI: 1.20\u20134.94,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.014), male sex, and Charlson Comorbidity Index. AKI was associated with older age at IBD diagnosis and a higher frequency of disease flares. In a multivariable model, IBD-related surgery was independently associated with urolithiasis (aOR: 2.20, 95% CI: 1.03\u20134.70,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.042).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Renal and urological complications are relatively common in IBD. IBD-related surgery, extensive ulcerative colitis, and cardiometabolic comorbidities are associated with renal injury, while IBD-related surgery is also independently associated with urolithiasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003249","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:00:09Z","timestamp":1784739609000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Renal and urological complications in patients with inflammatory bowel disease"],"prefix":"10.1097","author":[{"given":"Georgios","family":"Psarakis","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Drygiannakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Foteinogiannopoulou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Orfanoudaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"},{"name":"Department of Gastroenterology, General Hospital of Chania, Chania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Bettina","family":"Haidich","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Social-Preventive Medicine and Medical Statistics, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis E.","family":"Koutroubakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"R1-20260722","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-020-2025-2","article-title":"Pathway paradigms revealed from the genetics of inflammatory bowel disease.","volume":"578","author":"Graham","year":"2020","journal-title":"Nature"},{"key":"R2-20260722","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med"},{"key":"R3-20260722","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ibd.21468","article-title":"Renal manifestations and complications of inflammatory bowel disease.","volume":"17","author":"Oikonomou","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R4-20260722","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2004.03.016","article-title":"5-Aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.","volume":"126","author":"Van Staa","year":"2004","journal-title":"Gastroenterology"},{"key":"R5-20260722","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00535-022-01903-6","article-title":"Renal manifestations in inflammatory bowel disease: a systematic review.","volume":"57","author":"van Hoeve","year":"2022","journal-title":"J Gastroenterol"},{"key":"R6-20260722","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ecco-jcc\/jjae049","article-title":"Chronic kidney disease in inflammatory bowel disease: a systematic review and meta-analysis.","volume":"18","author":"Zadora","year":"2024","journal-title":"J Crohns Colitis"},{"key":"R7-20260722","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/j.crohns.2013.05.001","article-title":"Renal insufficiency in IBD \u2013 prevalence and possible pathogenetic aspects.","volume":"7","author":"Primas","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R8-20260722","first-page":"1846","article-title":"Frequency and risk factors of renal insufficiency in inflammatory bowel disease inpatients.","volume":"19","author":"Lewis","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R9-20260722","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/apt.15408","article-title":"No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case\u2013control study.","volume":"50","author":"Jairath","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20260722","doi-asserted-by":"crossref","first-page":"e936497","DOI":"10.12659\/MSM.936497","article-title":"Renal manifestations in inflammatory bowel disease: a cohort study during the biologic era.","volume":"28","author":"Dincer","year":"2022","journal-title":"Med Sci Monit"},{"key":"R11-20260722","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications.","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R12-20260722","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"R13-20260722","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R14-20260722","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R15-20260722","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.gie.2025.04.044","article-title":"Endoscopy in inflammatory bowel disease: what every endoscopist should know.","volume":"102","author":"Kochhar","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"R16-20260722","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity.","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"R17-20260722","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"R18-20260722","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"R19-20260722","doi-asserted-by":"crossref","first-page":"e2119123","DOI":"10.1001\/jamanetworkopen.2021.19123","article-title":"Evaluation of hemoglobin cutoff levels to define anemia among healthy individuals.","volume":"4","author":"Addo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R20-20260722","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/jcm9061704","article-title":"Acute kidney injury: from diagnosis to prevention and treatment strategies.","volume":"9","author":"Gameiro","year":"2020","journal-title":"J Clin Med"},{"key":"R21-20260722","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.juro.2007.09.107","article-title":"2007 guideline for the management of ureteral calculi.","volume":"178","author":"Preminger","year":"2007","journal-title":"J Urol"},{"key":"R22-20260722","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and cox regression.","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R23-20260722","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants.","volume":"333","year":"2025","journal-title":"JAMA"},{"key":"R24-20260722","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5414\/CNP61083","article-title":"Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?","volume":"61","author":"Elseviers","year":"2004","journal-title":"Clin Nephrol"},{"key":"R25-20260722","first-page":"381","article-title":"Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt.","volume":"81","author":"Elaziz","year":"2018","journal-title":"Acta Gastroenterol Belg"},{"key":"R26-20260722","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.3748\/wjg.v24.i42.4798","article-title":"Increased end-stage renal disease risk in patients with inflammatory bowel disease: a nationwide population-based study.","volume":"24","author":"Park","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R27-20260722","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.cgh.2019.10.043","article-title":"Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age.","volume":"18","author":"Vajravelu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-20260722","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/1751-2980.13233","article-title":"Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: a propensity score-matched analysis of US nationwide inpatient sample 2016\u20132018.","volume":"24","author":"Zheng","year":"2023","journal-title":"J Dig Dis"},{"key":"R29-20260722","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.amepre.2023.08.008","article-title":"Inflammatory bowel disease with chronic kidney disease and acute kidney injury.","volume":"65","author":"Liu","year":"2023","journal-title":"Am J Prev Med"},{"key":"R30-20260722","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14309\/ajg.0000000000002473","article-title":"Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease.","volume":"119","author":"Yang","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"R31-20260722","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00467-002-0943-x","article-title":"An adolescent with IgA nephropathy and Crohn\u2019s disease: pathogenetic implications.","volume":"17","author":"Takemura","year":"2002","journal-title":"Pediatr Nephrol (Berlin)"},{"key":"R32-20260722","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2036.2001.00940.x","article-title":"Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.","volume":"15","author":"Herrlinger","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-20260722","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1365-2036.2001.01041.x","article-title":"Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.","volume":"15","author":"Fraser","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R34-20260722","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3748\/wjg.v12.i5.739","article-title":"Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?","volume":"12","author":"Poulou","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R35-20260722","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"R36-20260722","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha; therapy for rheumatoid arthritis.","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R37-20260722","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11255-020-02649-x","article-title":"Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition.","volume":"53","author":"Torricelli","year":"2021","journal-title":"Int Urol Nephrol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:00:13Z","timestamp":1784739613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000003249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003249","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2026-02-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}